Medication Management & Stimulant Treatment Policy

Adult ADHD Care in Pennsylvania & Delaware

At ADHD Philadelphia, medication management is one component of a comprehensive treatment plan for adults with ADHD.

When clinically appropriate, stimulant medications can significantly improve focus, task initiation, working memory, and executive functioning. However, because these medications are federally regulated controlled substances, they require structured monitoring and responsible oversight.

Our approach prioritizes:

• Patient safety
• Evidence-based treatment
• Regulatory compliance
• Long-term treatment success

Below is a detailed explanation of how stimulant medication is managed in our practice.

Why Stimulant Medications Require Structured Monitoring

Stimulant medications such as amphetamine-based and methylphenidate-based treatments are classified as Schedule II controlled substances under federal law.

This classification reflects that these medications:

• Have well-established medical benefit when prescribed appropriately
• Carry potential for misuse or diversion
• Require ongoing medical supervision
• Must comply with Pennsylvania and Delaware prescribing regulations

Monitoring is not about mistrust.
It is about responsible medical care and patient protection.

Our 30-Day Monitoring Model

All stimulant treatment in our practice follows a structured 30-day review cycle.

This includes:

• Prescriptions typically written in 30-day supplies
• Regular follow-up appointments
• Review of symptom response
• Monitoring for side effects
• Ongoing evaluation of medical necessity
• Treatment adjustments when clinically indicated

Medication is continuously reassessed rather than prescribed indefinitely without review.

Prescription Drug Monitoring Program (PDMP)

Before issuing any stimulant prescription, we review the Prescription Drug Monitoring Program (PDMP).

The PDMP is a state-regulated database used in Pennsylvania and Delaware to:

• Promote patient safety
• Prevent duplicate controlled substance prescribing
• Identify potential drug interactions
• Reduce misuse and diversion

PDMP review is conducted prior to each stimulant prescription.

Cardiovascular Safety & Screening

Stimulant medications may increase heart rate and blood pressure.

Depending on your medical history, you may be asked to:

• Obtain an EKG prior to starting medication
• Provide medical clearance from a primary care provider or cardiologist
• Monitor blood pressure regularly
• Participate in follow-up cardiovascular assessments

Cardiovascular safety is evaluated before and during treatment.

Urine Drug Screening & Follow-Up Care

Because stimulant medications are controlled substances, structured monitoring may include:

• Periodic urine drug screening
• Scheduled follow-up appointments
• Occasional in-person visits when clinically indicated

Monitoring requirements are individualized based on clinical presentation and risk assessment.

Participation in follow-up care is part of responsible stimulant treatment.

Substance Use Policy

Because stimulant medications are regulated controlled substances, prescribing standards in our practice require abstinence from non-prescribed substances during treatment.

This includes:

• Cannabis and THC products (including medical marijuana)
• Illicit substances
• Misuse of alcohol
• Unauthorized prescription medications

This policy exists to:

• Reduce cardiovascular risk
• Reduce psychiatric risk
• Minimize medication interaction complications
• Maintain compliance with professional prescribing standards

If substance use concerns arise, stimulant treatment may be paused or discontinued for safety reasons.

We believe in transparency so patients understand expectations before beginning treatment.

Who May Not Be the Best Fit for Structured Stimulant Treatment

We may not be the ideal clinical match for individuals who:

• Prefer minimal monitoring
• Are unwilling to participate in structured follow-up
• Wish to combine stimulant treatment with cannabis use
• Seek early refills or non-structured prescribing

ADHD Philadelphia specializes in structured, safety-focused adult ADHD care.

Alternatives to Stimulant Medication

Stimulants are not the only treatment option for adult ADHD.

When clinically appropriate, alternatives may include:

• Non-stimulant medications
• Executive functioning support strategies
• ADHD-focused cognitive behavioral therapy
• Behavioral structure systems
• Sleep and lifestyle optimization

Treatment decisions are individualized based on medical history, symptom presentation, and clinical appropriateness.

Our Commitment to Responsible ADHD Care in PA & DE

We are committed to:

• Ethical prescribing
• Evidence-based treatment
• Transparent treatment standards
• Regulatory compliance
• Long-term patient safety

Our goal is not simply symptom reduction.

Our goal is sustainable, medically responsible ADHD management for adults in Pennsylvania and Delaware.

Questions About Medication Management?

If you have questions about whether stimulant treatment is appropriate for you, we are happy to discuss options during your evaluation.

You may also review:

• Adult ADHD Evaluation Process
• ADHD vs Anxiety in Adults
• Non-Stimulant Treatment Options

Ready to Begin?

Adults located in Pennsylvania and Delaware may schedule an evaluation online.

👉 Book Your ADHD Evaluation Today

Telehealth appointments are available throughout PA & DE.
In-person appointments may be scheduled after the initial telehealth visit when clinically indicated.